Valuation: Becton, Dickinson and Company

Market Cap 4.36TCr 3.81TCr 3.5TCr 3.26TCr 6.19TCr 4,14700Cr 6.28TCr 42TCr 16TCr 2,03900Cr 16TCr 16TCr 7,02500Cr P/E 2026 *
39.4x
P/E 2027 * 30.4x
Enterprise Value 5.95TCr 5.2TCr 4.78TCr 4.46TCr 8.45TCr 5,66600Cr 8.58TCr 57TCr 22TCr 2,78500Cr 22TCr 22TCr 9,59800Cr EV / Sales 2026 *
3.1x
EV / Sales 2027 * 2.92x
Free-Float
74.04%
Yield 2026 *
2.44%
Yield 2027 * 2.48%
1 day+3.39%
1 week+1.39%
Current month+4.46%
1 month+8.56%
3 months+2.31%
6 months-18.91%
Current year-18.54%
1 week 149.69
Extreme 149.69
158.72
1 month 140.11
Extreme 140.11
158.72
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.32TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
-1.04%+2.85%-11.67%-21.21% 2.03TCr
Average +2.50%+4.02%+4.30%-2.10% 5.59TCr
Weighted average by Cap. +3.16%+3.28%-4.20%+0.13%

Financials

2026 *2027 *
Net sales 1.92TCr 1.68TCr 1.54TCr 1.44TCr 2.73TCr 1,82900Cr 2.77TCr 19TCr 7.2TCr 90TCr 7.21TCr 7.05TCr 3,09700Cr 1.97TCr 1.72TCr 1.58TCr 1.48TCr 2.8TCr 1,87700Cr 2.84TCr 19TCr 7.39TCr 92TCr 7.4TCr 7.24TCr 3,17900Cr
Net income 112.46Cr 98Cr 90Cr 84Cr 159.74Cr 11TCr 162.16Cr 1.08TCr 421.67Cr 5.26TCr 422.14Cr 413.08Cr 18TCr 144.92Cr 126.69Cr 116.43Cr 108.52Cr 205.84Cr 14TCr 208.96Cr 1.4TCr 543.37Cr 6.78TCr 543.98Cr 532.3Cr 23TCr
Net Debt 1.6TCr 1.39TCr 1.28TCr 1.19TCr 2.27TCr 1,51900Cr 2.3TCr 15TCr 5.98TCr 75TCr 5.99TCr 5.86TCr 2,57300Cr 1.41TCr 1.23TCr 1.13TCr 1.05TCr 2TCr 1,34000Cr 2.03TCr 14TCr 5.28TCr 66TCr 5.28TCr 5.17TCr 2,27000Cr
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
02/26/02 $158.08 +3.39% 20,40,521
01/26/01 $152.90 +1.04% 21,31,647
30/26/30 $151.33 -2.49% 21,09,075
29/26/29 $155.19 -0.47% 23,96,596
26/26/26 $155.92 +3.00% 1,21,80,748
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
158.08USD
Average target price
177.75USD
Spread / Average Target
+12.44%

Quarterly revenue - Rate of surprise